Worried About a Stock Market Crash? History Says Don't Sweat It. These three historical indicators show that investors should continue adding to their portfolios amid market volatility.
After Crashing 45% in 180 Days, Is Bitcoin Still a Buy? Bitcoin is the leading cryptocurrency, and it has been falling hard; be careful if you're considering buying any.
President Sells shares worth $1.0 Million at His Own Discretion This compliance software provider reported a notable insider sale, as direct holdings were reduced above the recent median pace.
MSC Industrial (MSM) Q1 Earnings: What To Expect Industrial supplies company MSC Industrial Direct (
NYSE:MSM ) will be announcing earnings results this Wednesday before the bell. Here’s what you need to know...
Earnings To Watch: UniFirst (UNF) Reports Q1 Results Tomorrow Workplace uniform provider UniFirst (
NYSE:UNF ) will be announcing earnings results this Wednesday before market hours. Here’s what you need to know. UniFirst...
Iran, Russia Using Crypto To Buy Military Drones? Report Reveals E-Commerce Platforms Used To Sell Equipment To 'Opaque' Identities Russia and Iran-linked actors increasingly use cryptocurrency to fund low-cost drone purchases for conflicts, blockchain analytics firm Chainalysis reported Monday, March 30.
Nvidia's Rubin Chip Arrives in Late 2026. Is Now the Time to Buy This Artificial Intelligence (AI) Stock? Nvidia is ready to launch its next-generation chip platform, but there are other factors to consider before you buy the stock.
3 Beaten-Down Software Stocks: 2 to Avoid and 1 to Buy These three software giants have all taken a hit this year, but only one looks like a buy.
Cathie Wood Just Snapped Up This Nvidia Cloud Play — Here's Everything Else Ark Traded Monday On Monday, March, 30, 2026, Ark Invest bought nearly $3M of CoreWeave stock while also shedding shares of Teradyne and Veracyte.
Alphabet vs. Amazon: Both AI Stocks Have Been Hammered, but One Looks Like a Better Buy Now Both tech giants have suffered in the recent market pullback, but one presents a more compelling artificial intelligence growth story today.
Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD This specialty pharma firm focused on pain management therapies reported a notable insider sale amid steady revenue and recent stock gains.
Sionna Chief Legal Officer Cashed Out Her Shares. Her Options Are Another Story This biotech innovator in cystic fibrosis therapies reported a notable insider sale, as disclosed in recent SEC filings.
Is QQQ Still Worth Buying After the Market's Recent Slide? The Invesco QQQ ETF is 8% below its all-time high as I write this. Is this a good buying opportunity?
